Trending...
- Veteran Antiques Expert John Swahn Releases New Book: The Truth About Antiques
- Hope Survives Managing Director Jasmine Balignasay-Chavez Receives 2026 Catalyst Award
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
Formal seven page statement on behalf of the manosphere community by President Anthony Dream Johnson regarding the recent events surrounding John Goldman aka "Jack Murphy" and Denver shooting spree killer Lyndon McLeod aka "Roman McClay".
ORLANDO, Fla. & DENVER - PennZone -- 1st President of the Manosphere Anthony Dream Johnson has released a formal seven page statement on the recent issues and events surrounding author John Goldman aka "Jack Murphy" and Colorado shooting spree killer Lyndon McLeod aka "Roman McClay".
This statement concerning recent tragic events in Denver, Colorado can be found here at 21Studios.com as well as at TheManosphere.org here. This statement also addresses the "Liminal Order" men's group founded by Jack Murphy that mass shooter Roman McClay was once a part of.
More on The PennZone
The statement can be downloaded here in PDF form.
Previous press releases from Anthony Dream Johnson can be found here.
This statement concerning recent tragic events in Denver, Colorado can be found here at 21Studios.com as well as at TheManosphere.org here. This statement also addresses the "Liminal Order" men's group founded by Jack Murphy that mass shooter Roman McClay was once a part of.
More on The PennZone
- PinnacleQM launches new enterprise website to help Australian organisations deliver more with confidence
- 33,714 US social services nonprofits and the funding calls still open to them
- Loud! OOH Launches UK's First Free Planning Tool for UK Outdoor Advertising Budgets
- Local Man Needs Assistance with Housing
- Carew Papritz Revisits His Reading Eagle Op-Ed on Dolly Parton Ahead of CMA Awards Tribute
The statement can be downloaded here in PDF form.
Previous press releases from Anthony Dream Johnson can be found here.
Source: The 21 Convention LLC
0 Comments
Latest on The PennZone
- ET&T Named Philadelphia Business Journal Family-Owned Business Awards Honoree
- What If the Greatest Gift This Holiday Season Came in a Dream of Your Loved One in Spirit?
- 6,238 executives took new roles at US nonprofits from June to October 2026
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Minneapolis
- LGF Lab Gas Flow Launches Fully Automatic Laboratory Gas Changeover Manifold System with Ultra High Purity Gas Regulator Valve
- Woodside Village Joins Corner Property Management Following CMP Acquisition
- 20-Year Crash Cost of Signalized RC3 Cloverleaf Could Exceed $25 Million
- Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
- Inaugural 12 Trees of Christmas gala raises $525,000 for DMG research and family support
- BitTitan Expands MigrationWiz with SharePoint Sites Migration and Simplified Collaboration Licensing
- Olympic champion Katie Moon to compete at Pole Vault in Paradise in Key West
- Smith Strong Merges With Gravis Law, Bringing Gravis Law to Virginia
- Angela's Boutique Highlights Self-Care Gifts for Philadelphia Holiday Shoppers
- Turkish Engineer Who Cracked Wall Street's Algorithm Launches Hermes AI Analyzer
- UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
- Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
- Emerald Williams Selected to Super Lawyers Rising Stars 2022-2026
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc

